CureVac

CureVac, mRNA influenza vaccine, mRNA vaccine, GSK, mRNA tech­nology platform

CureVac selects mRNA flu vaccine candidate for GSK collaboration, but data remains secret

Anika Sharma

CureVac, the renowned biotech company, has made a significant stride in its quest to develop an mRNA influenza vaccine. While ...

Moderna, Pfizer, COVID-19 Vaccine, mRNA vaccines, Alnylam Pharmaceuticals, CureVac, BioNTech, Patent infringement

Legal Engagements Amid Scientific Advancements: Alnylam’s Ongoing Interplay with Moderna

Anika Sharma

In the intricate choreography of the biopharmaceutical world, where innovation and intellectual property intertwine, a dramatic legal ballet unfolds. Alnylam, ...

In its COVID-19 vaccination lawsuits against Pfizer and BioNTech, CureVac makes further claims under the patent statute

In its COVID-19 vaccination lawsuits against Pfizer and BioNTech, CureVac makes further claims under the patent statute

SG Tylor

Source – CureVac CureVac is intensifying its patent battle over COVID-19 vaccines by asserting additional claims against Pfizer and BioNTech ...